Generation Bio Co Stock Performance
| GBIO Stock | USD 4.62 0.42 10.00% |
On a scale of 0 to 100, Generation Bio holds a performance score of 2. The company retains a Market Volatility (i.e., Beta) of 2.07, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Generation Bio will likely underperform. Please check Generation Bio's sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change , to make a quick decision on whether Generation Bio's current trending patterns will revert.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Generation Bio Co are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady forward indicators, Generation Bio displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 11.87 | Five Day Return 5.82 | Year To Date Return (57.67) | Ten Year Return (98.10) | All Time Return (98.10) |
Last Split Factor 1:10 | Last Split Date 2025-07-22 |
1 | Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results | 05/07/2025 |
2 | Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference GBIO Stock News | 05/28/2025 |
3 | Acquisition by Appelhans Dannielle of 30000 shares of Generation Bio at 0.3874 subject to Rule 16b-3 | 06/04/2025 |
4 | Generation Bio Elects Directors and Approves Key Proposals - TipRanks | 06/05/2025 |
5 | Acquisition by Stehman-breen Catherine of 30000 shares of Generation Bio at 0.3874 subject to Rule 16b-3 | 06/06/2025 |
6 | Generation Bio Announces Inducement Grant under Nasdaq Listing Rule 5635 | 07/07/2025 |
7 | Disposition of 5273 shares by Mcdonough Geoff of Generation Bio subject to Rule 16b-3 | 07/15/2025 |
8 | Acquisition by Nicholson Donald William of 30000 shares of Generation Bio at 0.3874 subject to Rule 16b-3 | 07/16/2025 |
9 | Generation Bio Announces 1-for-10 Reverse Stock Split GBIO Stock News | 07/18/2025 |
10 | BlackRock, Inc. Reduces Stake in Generation Bio Co by 66.17 | 07/24/2025 |
| Begin Period Cash Flow | 72.2 M | |
| Total Cashflows From Investing Activities | 94.5 M |
Generation | Build AI portfolio with Generation Stock |
Generation Bio Relative Risk vs. Return Landscape
If you would invest 431.00 in Generation Bio Co on April 26, 2025 and sell it today you would lose (11.00) from holding Generation Bio Co or give up 2.55% of portfolio value over 90 days. Generation Bio Co is currently generating 0.229% in daily expected returns and assumes 7.5503% risk (volatility on return distribution) over the 90 days horizon. In different words, 67% of stocks are less volatile than Generation, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Generation Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Generation Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Generation Bio Co, and traders can use it to determine the average amount a Generation Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0303
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | GBIO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.55 actual daily | 67 67% of assets are less volatile |
Expected Return
| 0.23 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Generation Bio is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Generation Bio by adding it to a well-diversified portfolio.
Generation Bio Fundamentals Growth
Generation Stock prices reflect investors' perceptions of the future prospects and financial health of Generation Bio, and Generation Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Generation Stock performance.
| Return On Equity | -0.7 | ||||
| Return On Asset | -0.19 | ||||
| Profit Margin | (2.93) % | ||||
| Operating Margin | (1.77) % | ||||
| Current Valuation | (41.84 M) | ||||
| Shares Outstanding | 6.7 M | ||||
| Price To Book | 0.38 X | ||||
| Price To Sales | 1.15 X | ||||
| Revenue | 19.89 M | ||||
| Gross Profit | (24.16 M) | ||||
| EBITDA | (74.26 M) | ||||
| Net Income | (131.67 M) | ||||
| Cash And Equivalents | 301.17 M | ||||
| Cash Per Share | 5.07 X | ||||
| Total Debt | 93.56 M | ||||
| Debt To Equity | 0.27 % | ||||
| Current Ratio | 17.93 X | ||||
| Book Value Per Share | 10.94 X | ||||
| Cash Flow From Operations | (88.56 M) | ||||
| Earnings Per Share | (10.80) X | ||||
| Market Capitalization | 28.14 M | ||||
| Total Asset | 231.2 M | ||||
| Retained Earnings | (703.04 M) | ||||
| Working Capital | 157.85 M | ||||
About Generation Bio Performance
By examining Generation Bio's fundamental ratios, stakeholders can obtain critical insights into Generation Bio's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Generation Bio is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.57) | (0.60) | |
| Return On Capital Employed | (0.73) | (0.76) | |
| Return On Assets | (0.57) | (0.60) | |
| Return On Equity | (1.53) | (1.45) |
Things to note about Generation Bio performance evaluation
Checking the ongoing alerts about Generation Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Generation Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Generation Bio had very high historical volatility over the last 90 days | |
| Generation Bio has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 19.89 M. Net Loss for the year was (131.67 M) with loss before overhead, payroll, taxes, and interest of (24.16 M). | |
| Generation Bio Co currently holds about 301.17 M in cash with (88.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.07, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Generation Bio has a poor financial position based on the latest SEC disclosures | |
| Roughly 72.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: BlackRock, Inc. Reduces Stake in Generation Bio Co by 66.17 |
- Analyzing Generation Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Generation Bio's stock is overvalued or undervalued compared to its peers.
- Examining Generation Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Generation Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Generation Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Generation Bio's stock. These opinions can provide insight into Generation Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation Bio. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.80) | Revenue Per Share | Quarterly Revenue Growth 1.149 | Return On Assets | Return On Equity |
The market value of Generation Bio is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation Bio's value that differs from its market value or its book value, called intrinsic value, which is Generation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation Bio's market value can be influenced by many factors that don't directly affect Generation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.